Emcure Pharmaceuticals Receives USFDA Form 483 With Seven Observations
Emcure Pharmaceuticals received a USFDA Form 483 with seven observations following a cGMP inspection at its Sanand manufacturing facility in Gujarat.
Alkem Laboratories Gets USFDA Form 483 With 7 Observations At Daman Facility
Alkem Laboratories faces USFDA scrutiny after receiving seven observations at its Daman plant, weeks after securing EU GMP certification.
